Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic CancerByDr. Kristin HigginsAugust 27th 2026
FDA Approves Ziihera Combinations for First-Line Treatment of HER2-Positive Gastroesophageal CancerByQuincy AttobrahAugust 25th 2026
This Oncology Nurse Stayed by Her Patient's Side Until His Very Last DaysByKay Kroeff StrengAugust 23rd 2026
Blood Test May Identify Who Benefits From Sirexatamab in Colorectal CancerByKaitlyn M. LeAugust 12th 2026